Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 3184 (MIR3184) is a small, non-coding RNA molecule (microRNA; ~20-24 nucleotides) found in humans and involved in post-transcriptional regulation of gene expression, primarily by promoting mRNA degradation or inhibiting translation[3][5]. MIR3184 is enriched in cerebrospinal fluid exosomes from glioma patients and is linked to tumor progression by directly promoting glioma cell proliferation, migration, invasion, as well as inhibiting apoptosis. Additionally, glioma-derived exosomal MIR3184 can polarize macrophages toward an immunosuppressive M2-like phenotype, further enhancing tumor growth and immune evasion. As such, MIR3184 represents a potential biomarker for glioma and may indirectly influence tumor biology via effects on both tumor cells and the tumor immune microenvironment, but is not a classic therapeutic receptor or enzyme target[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 3184 (MIR3184).